新京报讯(记者陈琳)10月11日，由北京市市场监管局主办的"在京全国标委会与北京市重点产业企业对 接会成果发布暨第56届世界标准日主题活动"在京举行。活动以"增强伙伴关系共促可持续发展"为主 题，集中发布了三项对接成果，包括"在京全国标委会与北京市重点产业企业对接会成果""北京市服务 业标准化案例集"和"北京市高质量团体标准案例集"。 活动同期发布了《北京市服务业标准化案例集》和《北京市高质量团体标准案例集》，收录了涵盖文旅 服务、养老服务、金融IC卡、人工智能等领域的30余个服务业案例和14个团体标准案例，为更多企业实 施标准化管理提供了可复制、可推广的实践参考。 在医疗装备产业对接中，3家相关标委会共同参与，为企业提供细分领域全链条标准指导；平谷区物流 仓储对接活动则邀请国际起重机标准化技术委员会(ISO/TC96)主席现场解读国内外物流标准动态，助力 企业融入国际供应链。 标准化成果持续涌现。自2025年1月以来，北京市已在城市可持续发展、碳排放管理、智能运输系统、 新材料等领域推动1000余项国家标准立项，并在通信、物流、集成电路等关键领域发布国家标准800余 项。 今年以来，北京市持续深化在京全国专 ...

Policy Developments - The Ministry of Industry and Information Technology, along with two other departments, announced the initiation of the 2025 high-end medical equipment promotion application project [1] Drug and Device Approvals - Baicheng Pharmaceutical received clinical trial approval for its innovative drug BIOS-0623-Z4, aimed at treating cancer pain in adults, with no similar drugs currently on the market [2] - Heng Rui Medicine's subsidiary received approval for clinical trials of HRS-2129, targeting diabetic peripheral neuropathic pain and osteoarthritis pain, with a total R&D investment of approximately 112 million yuan [3] - Borui Pharmaceutical obtained FDA approval for the clinical trial of BGM1812 injection for overweight or obesity treatment, with no similar products approved globally [4] Capital Market - Hangzhou Yaojiasu Medical Isotope Technology Co., Ltd. announced the completion of several million yuan in angel round financing, aimed at expanding its core team and advancing technology development [5] Industry Events - The National Medical Insurance Administration has identified and addressed multiple cases of abnormal data, enhancing the regulatory capabilities of medical insurance data [7] - Xiangyu Medical signed a cooperation agreement with Zhejiang Provincial People's Hospital to establish a clinical research ward for brain-machine interfaces [8] - A micro "lung chip" with an embedded immune system was developed by researchers from Georgia Tech and Vanderbilt University, potentially revolutionizing disease research [9] Public Opinion Alerts - Shenqi Pharmaceutical faced a significant stock drop after being ordered to rectify issues related to the misappropriation of 44.83 million yuan in sales fees, leading to regulatory actions [10]

人民财讯9月29日电，工业和信息化部、国家卫生健康委、国家药监局三部门近日印发通知，组织开展 2025年高端医疗装备推广应用项目申报工作。本次推广应用项目重点面向高端医疗装备重点产品和典型 场景，遴选一批技术创新水平与临床应用水平处于全国前列，对医工协同创新、中试验证、临床研究、 迭代升级与推广应用等具有较强引领带动作用的项目。本年度重点开展5类重点产品和4类典型场景的推 广应用。 ...

全球医疗困局倒逼AI变革 当前，全球医疗市场总规模已接近10万亿美元。美国作为最大医疗支出国，2023年卫生总支出突破4.9万亿美元，其中约75%用于服务端。然而，医护资源 短缺问题日益严峻：2023年，16.7%的美国医院预见到关键岗位人力不足，预计到2031年每年需填补超20万个护理职位。与此同时，65岁以上人口已达4600 万，2050年将翻倍至9000万，慢性病与长期护理需求激增。 在政策与市场需求双重驱动下，迈纳士（Minauth）率先推出"基层医疗AI诊断工程"，以"AI+微流控+区块链"技术为核心，打造覆盖县域医共体的智能采检 闭环，破解基层医疗"不可能三角"。公司核心产品——"Magic Lab智能诊断体"已于2025年5月获得国家二类医疗器械注册证，正式进入临床应用阶段。该设 备集自动采血机器人与多功能分析仪于一体，实现从采血、检测到报告生成的全流程自动化，真正构建"一平米检验科"。 另一方面，全流程自动化不仅显著提升效率，更有效避免了传统模式下因人工操作、样本转运带来的误差、延误与污染风险。尤其在标本外送需6小时以上 的偏远地区，迈纳士的采检一体机实现了"即时诊断、即时干预"的突破，大幅提 ...

Core Insights - The Ministry of Industry and Information Technology issued the "Guidelines for Promoting Digital Transformation in Key Industries (2025 Edition)" on September 16 [1] - The guidelines include scenario maps for 14 key industries, such as steel, petrochemicals, engineering machinery, new energy vehicles, robotics, medical equipment, home appliances, sugar production, liquor, beauty and daily chemicals, lithium batteries, printed circuit boards (PCB), smart mobile terminals, and civil explosives [1] - The document emphasizes the dynamic updating of scenario maps based on technological advancements and industry developments [1] - Other industries are encouraged to explore the construction of "one map and four lists" [1]

Core Viewpoint - The Changping district has made significant progress in its economic development and innovation initiatives over the past five years, with a focus on attracting foreign investment and enhancing its open economy [1][2]. Group 1: Economic Development - Over the past five years, Changping has launched over 1,900 projects and established 329 new foreign-funded enterprises, achieving an annual growth rate of 28.2% [1]. - The actual utilization of foreign capital reached $1.68 billion, indicating a continuous rise in the district's open economic strength [1]. Group 2: Policy Innovation - Changping has implemented over 20 special policies, including the Free Trade Zone implementation plan, and has introduced 210 high-value measures [1]. - Notable firsts include the establishment of the first international research hospital in the country and the first decentralized clinical trial pilot [1]. Group 3: Financial and Intellectual Property Innovations - The district has introduced the first cross-border RMB settlement incentive policy in the city and established integrated cross-border fund pools [1]. - A "see investment and lend" service mechanism has been created, along with a new model combining technology, insurance, and services to protect intellectual property for overseas innovations [1]. Group 4: Talent and Industry Development - The Future Science City "Life Valley" has attracted over 300 high-level talents and 118 enterprises founded by scientists [2]. - The "Energy Valley" has collaborated with 18 central enterprises and 10 academic workstations, creating over 220 international standards and more than 16,000 effective patents [2]. Group 5: Business Environment and Investment Attraction - Changping has improved its business environment by streamlining the registration process for foreign-invested enterprises to a one-day online service [2]. - The district aims to focus on innovation across the entire pharmaceutical and health industry chain, enhance the construction of key parks, and optimize investment attraction strategies [2].

5年来，累计落地项目1939个，新设外资企业329家，新设外资研发中心19家，实际使用外资达16.8亿美 元。9月10日，昌平区举办"两区"建设五周年新闻发布会，这也是2025年中国国际服务贸易交易会新闻 中心首场新闻发布会。会上，昌平区委常委、区政府党组成员、副区长柳强公布了昌平"两区"建设成绩 单，他表示，"两区"建设以来，昌平实现了从"开放试验田"向"发展新高地"的跨越。 出台20余项政策，多个全国首创成果落地生根 另一方面，昌平加快推进服务业扩大开放综合示范区主窗口建设。在未来科学城能源谷，集聚18家参建 央企、10个院士工作站，建成24个协同创新平台，创制国际标准超220项，获评有效专利超1.6万件，成 功入选北京市重点产业集聚区，能源领域创新实力持续领跑；在沙河高教园，已入驻8所高校、120个国 家及省部级实验室，校地协同创新成效显著。中关村昌平园加速推进扩区提质，获批上市的创新医疗 （002173）器械产品数量占全国总量约1/10，医疗装备创新领域核心地位愈发突出。 外资规模结构双优，上半年出口额增速领跑全市 昌平区商务局党组成员、副局长张馨提到，自"两区"建设以来，昌平区实际利用外资规模实现倍 ...

Core Points - The Chongqing Economic and Information Commission officially released the third batch of major technological equipment products, highlighting breakthroughs in high-end equipment research and industrial upgrades in Chongqing [1] - The new products cover six key areas: intelligent manufacturing, energy conservation and environmental protection, power and electrical, transportation, intelligent detection, and medical equipment [1] - Notable products include a coal mine gas extraction drilling robot, a heavy-duty robotic arm joint reducer, an intelligent ventilation controller, a dual-flow urban train, and a nano time gauge [1] Summary by Category Product Highlights - The coal mine gas extraction drilling robot is the first of its kind in China, integrating positioning navigation, autonomous movement, condition perception, and automatic drilling [1] - The heavy-duty robotic arm joint reducer fills a gap in the domestic market for precision joint reducers used in electric-driven heavy-duty robotic arms [1] - The intelligent ventilation controller is the first electromechanical integrated product in the ventilation market, enhancing the localization level of core components [1] - The dual-flow urban train utilizes a domestically developed dual-flow automatic switching technology for interconnectivity between suburban and urban areas [1] - The nano time gauge breaks through traditional displacement measurement technology limitations, overcoming foreign technological barriers in precision displacement measurement [1] Collaboration and Market Impact - Several companies in Chongqing signed cooperation agreements with research institutes and key user units across various fields, including rail transportation, clean energy, intelligent manufacturing, and green environmental protection [2] - The implementation of these projects is expected to accelerate the application of major technological equipment from "first set" to "multiple sets," expanding market application space [2] - Since 2015, nearly 700 equipment products have been included in the first set promotion directory, achieving sales of over 1,500 sets, amounting to more than 8 billion yuan [2] - As of 2023, Chongqing has recognized 97 companies with 160 products, continuously promoting the transformation of technological breakthroughs into real production capacity [2]

Core Insights - Nicaragua's government representatives, including presidential advisor Laureano, visited Wandong Medical's Beijing R&D and manufacturing base, marking a significant step in high-end medical equipment cooperation between the two countries [1][3] - The visit aligns with Wandong Medical's "4+2+4" strategy, expanding its presence in Latin America, particularly after a recent partnership with Brazil [3][4] Group 1 - The delegation praised Wandong Medical's diverse innovative products and advanced manufacturing capabilities, especially the helium-free products' value for Nicaragua and Latin America [3] - An important consensus was reached to expedite the introduction of large imaging equipment into Nicaragua's public hospitals, aiming to provide quality products and services to local patients [3] - Wandong Medical is building a comprehensive industrial ecosystem in local markets through localized manufacturing, technology adaptation, and service network establishment [3] Group 2 - Wandong Medical's overseas expansion is supported by Midea Group's global resources, which include 38 R&D centers and 44 production bases across over 200 countries [3] - The company's equipment is installed in over 110 countries, continuously enhancing the "global R&D + local manufacturing + regional service" innovation model [3] - The company aims to leverage Midea Group's advantages to accelerate localization overseas, benefiting global populations, especially in Belt and Road Initiative countries [4]

Group 1 - The establishment of the Honghui Yuyi Fund marks the first smart medical equipment fund in Chongqing, with a scale of 500 million yuan, where 80% of the raised funds will be invested in the healthcare sector, contributing to the high-quality development of the biopharmaceutical industry in the region [1] - The biopharmaceutical industry is a key focus within Chongqing's "33618" modern manufacturing cluster system, identified as a trillion-level key industry, essential for upgrading the manufacturing sector towards high-end and intelligent development [1][2] - The fund aims to invest in core areas such as innovative drugs, medical devices, and medical consumables, targeting high-growth and innovative potential enterprises, while also pursuing long-term stable asset appreciation [2] Group 2 - Nantou Group has established 10 strategic industry guidance funds with a total scale of 4.53 billion yuan, primarily targeting the biopharmaceutical and optoelectronic sectors, and has invested in 36 projects [2] - The healthcare sector is experiencing a dual windfall from policy support and increasing demand, driven by factors such as global population aging and rising chronic disease rates, leading to a surge in demand for innovative drugs and medical equipment [2] - Honghui Fund (HLC), the fund manager, manages nearly 30 billion yuan in dual-currency funds and has invested in over 180 companies, with a successful exit from 82 companies, including 32 through IPOs, indicating strong potential for the new fund [3]